Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations

Operationalizing selection criteria for clinical trials in Alzheimer's disease: Biomarker and clinical considerations

Abstract Alzheimer's disease (AD) staging criteria lack standardized, empirical description. Well‐defined AD staging criteria are an important consideration in protocol design, influencing a more standardized inclusion/exclusion criteria and defining what constitutes meaningful differentiation...

Full description

Bibliographic Details
Main Authors: Ronald C. Petersen, Ana Graf, Chris Brady, Susan De Santi, Hana Florian, Jaren Landen, Mike Pontecorvo, Christopher Randolph, Kaycee M. Sink, Maria C. Carrillo, Christopher J. Weber
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
Alzheimer's disease
amyloid
biomarkers
clinical trials
cognition
cognitive impairment
Online Access:https://doi.org/10.1002/trc2.12434

Internet

https://doi.org/10.1002/trc2.12434

Similar Items